ASKELA is a pharmacy in Chièvres. Private Limited, started on 27 April 2011, 1 establishment.

What is the address of ASKELA?

The registered office of ASKELA is located at Rue de l'Eglise 48, 7950 Chièvres.

Is ASKELA still active?

Yes. According to the CBE (29 October 2026) ASKELA is active, legal situation “Normale toestand”, started on 27 April 2011.

Is ASKELA registered on Peppol?

Yes, ASKELA is registered on the Peppol network with ID 0208:0835952928.

What is the enterprise number of ASKELA?

The enterprise number of ASKELA is BE0835952928.

When was ASKELA founded?

ASKELA was founded on 27 April 2011.

Who are the directors of ASKELA?

According to the 2025 annual accounts, the directors of ASKELA are: PHARMACOACH SRL, Paul RANSART.

Is ASKELA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 April 2011; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did ASKELA make in 2025?

ASKELA posted a profit after taxes of € 28,346 in financial year 2025.

What is the revenue of ASKELA?

As a small company, ASKELA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 25,341.

ASKELA (Private Limited) - Chièvres - BE0835952928

Dossier ASKELA, printed on 29 October 2026 from databakkes.be/en/0835952928/askela. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ASKELA from Chièvres, company number BE0835952928, closed financial year 2025 with a result of € 28,346 after tax. For that financial year ASKELA recorded a gross margin of € 25,341 and equity of € 291,736. Compared with financial year 2024, the result moved from € 37,672 to € 28,346. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.

What it is worth Growing

€ 291,736

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 28,346

▼ 25% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 65,895

▲ € 59,303 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -8,264.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 1,507

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 16,054 Gross margin 2022: € 16,054 First fiscal year in the series	€ 38,681 Gross margin 2023: € 38,681 ▲ 141% vs 2022 (€ 16,054) Favourable step	€ 35,331 Gross margin 2024: € 35,331 ▼ 9% vs 2023 (€ 38,681) Unfavourable step	€ 25,341 Gross margin 2025: € 25,341 ▼ 28% vs 2024 (€ 35,331) Unfavourable step	▼ 28%
Profit after taxes	€ 17,875 Profit after taxes 2022: € 17,875 First fiscal year in the series	€ 37,077 Profit after taxes 2023: € 37,077 ▲ 107% vs 2022 (€ 17,875) Favourable step	€ 37,672 Profit after taxes 2024: € 37,672 ▲ 2% vs 2023 (€ 37,077) Favourable step	€ 28,346 Profit after taxes 2025: € 28,346 ▼ 25% vs 2024 (€ 37,672) Unfavourable step	▼ 25%
Equity	€ 188,640 Equity 2022: € 188,640 First fiscal year in the series	€ 225,718 Equity 2023: € 225,718 ▲ 20% vs 2022 (€ 188,640) Favourable step	€ 263,390 Equity 2024: € 263,390 ▲ 17% vs 2023 (€ 225,718) Favourable step	€ 291,736 Equity 2025: € 291,736 ▲ 11% vs 2024 (€ 263,390) Favourable step	▲ 11%
Total debts	€ 6,692 Total debts 2022: € 6,692 First fiscal year in the series	€ 16,485 Total debts 2023: € 16,485 ▲ 146% vs 2022 (€ 6,692) Unfavourable step	€ 8,693 Total debts 2024: € 8,693 ▼ 47% vs 2023 (€ 16,485) Favourable step	€ 1,558 Total debts 2025: € 1,558 ▼ 82% vs 2024 (€ 8,693) Favourable step	▼ 82%
Cash	€ 8,117 Cash 2022: € 8,117 First fiscal year in the series	€ 623 Cash 2023: € 623 ▼ 92% vs 2022 (€ 8,117) Unfavourable step	€ 6,592 Cash 2024: € 6,592 ▲ € 5,969 vs 2023 (€ 623) Favourable step	€ 65,895 Cash 2025: € 65,895 ▲ € 59,303 vs 2024 (€ 6,592) Favourable step	▲ € 59,303
Retained profit	€ -111,360 Retained profit 2022: € -111,360 First fiscal year in the series	€ -74,282 Retained profit 2023: € -74,282 ▲ € 37,077 vs 2022 (€ -111,360) Favourable step	€ -36,610 Retained profit 2024: € -36,610 ▲ € 37,672 vs 2023 (€ -74,282) Favourable step	€ -8,264 Retained profit 2025: € -8,264 ▲ € 28,346 vs 2024 (€ -36,610) Favourable step	▲ € 28,346
Balance sheet total	€ 195,333 Balance sheet total 2022: € 195,333 First fiscal year in the series	€ 242,202 Balance sheet total 2023: € 242,202 ▲ 24% vs 2022 (€ 195,333) Unchanged	€ 272,083 Balance sheet total 2024: € 272,083 ▲ 12% vs 2023 (€ 242,202) Unchanged	€ 293,294 Balance sheet total 2025: € 293,294 ▲ 8% vs 2024 (€ 272,083) Unchanged	▲ 8%

Key figures of ASKELA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ASKELA?

What happened at ASKELA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 23, 2026 New annual accounts for financial year 2025: profit of € 28,346 (▼ 25% vs 2024). Source: NBB ↗
2019 PHARMACOACH SRL became a director. NBB
2019 Paul RANSART became a director. NBB
May 1, 2011 New establishment in Honnelles. KBO
Apr 27, 2011 Start of the company according to the CBE. KBO